Nivolumab/pembrolizumabMyasthenia gravis: case report

被引：0

作者：

机构：

来源：

Reactions Weekly | 2019年 / 1751卷 / 1期

关键词：

D O I：

10.1007/s40278-019-61433-2

中图分类号：

学科分类号：

摘要：

引用

页码：300 / 300

共 50 条

[41] PembrolizumabMyasthenia gravis and myositis
Reactions Weekly, 2024, 2014 (1) : 554 - 554
[42] Immune-globulin/methylprednisolone/pembrolizumabMyasthenia-gravis and lack of efficacy: case report
Reactions Weekly, 2021, 1870 (1) : 159 - 159
[43] PembrolizumabMyasthenia gravis, myositis and myocarditis
Reactions Weekly, 2024, 2014 (1) : 555 - 555
[44] Ipilimumab/nivolumab/pembrolizumabMyasthenia-like syndrome and paraspinal myositis associated with extraocular muscle atrophy: case report
Reactions Weekly, 2020, 1791 (1) : 152 - 152
[45] Ipilimumab/nivolumabMyasthenia gravis (first report for nivolumab) progressing to respiratory failure : case report
Reactions Weekly, 2015, 1564 (1) : 128 - 128
[46] Nivolumab/relatlimabMyocarditis, myositis and myasthenia gravis-like syndrome: case report
Reactions Weekly, 2025, 2052 (1) : 330 - 330
[47] Nivolumab/Prednisolone/PyridostigmineMyasthenia gravis with myositis overlap syndrome and lack of efficacy: case report
Reactions Weekly, 2024, 2024 (1) : 363 - 363
[48] Nivolumab/pemetrexed/prednisoloneMyositis, autoimmune myocarditis, myasthenia gravis and lack of efficacy: case report
Reactions Weekly, 2023, 1944 (1) : 452 - 452
[49] Nivolumab/pembrolizumabDrug toxicity in the form of neurotoxicity, hepatotoxicity, myositis, myocarditis and myasthenia gravis: case report
Reactions Weekly, 2023, 1949 (1) : 346 - 346
[50] Nivolumab-related myasthenia gravis with myositis requiring prolonged mechanical ventilation: a case report
Saishu, Yumi
Yoshida, Takuya
Seino, Yusuke
Nomura, Takeshi
JOURNAL OF MEDICAL CASE REPORTS, 2022, 16 (01)

← 1 2 3 4 5 →